Sanofi Consumer Healthcare
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Sanofi Consumer Healthcare India Limited (SCHIL) is strategically positioning itself for growth by focusing on high-potential segments such as nutraceuticals and preventive wellness, as highlighted by management's commitment to a more agile organizational structure. This pivot aligns with the evolving consumer preference for proactive health management, which is expected to drive revenue growth despite a backdrop of moderating overall growth rates. Vista's financial outlook reflects this optimism, projecting improving margins as the company enhances its operational efficiency and brand equity. The anticipated 34.45% upside in valuation is supported by a strong balance sheet and a fair valuation that aligns with intrinsic value. However, the company must navigate challenges such as rising input costs and geopolitical risks that could impact margins and operational stability. Over the next 12-24 months, key opportunities include leveraging AI for operational optimization and expanding market presence, while watchpoints include inflationary pressures and supply chain volatility that could hinder growth prospects
Why We Like This Stock
- Management's focus on high-growth segments like nutraceuticals aligns with consumer trends towards proactive health management
- Improving margins are expected as the company enhances operational efficiency and brand equity
- A strong balance sheet supports the company's strategic initiatives and positions it well for future growth
Things To Watch Out For
- Rising input costs and inflationary pressures could impact profitability and margin expansion
- Geopolitical risks and supply chain volatility remain significant concerns for operational stability
- Cautious investor sentiment may affect market performance despite the company's strong fundamentals
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 555 | 724 | 878 | 939 | 1,055 |
| Profit Before Tax (Cr.) | 247 | 240 | 313 | 356 | 394 |
| PBT Margin | 44.6% | 33.2% | 35.7% | 38.0% | 37.4% |
| Net Profit (Cr.) | 185 | 172 | 233 | 265 | 294 |
| Earnings Per Share | 80.4 | 74.9 | 101.4 | 115.4 | 127.7 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.